DDX5 and neoplasm: Together, these findings underscore how DDX5 functions as a signaling-responsive regulator whose impact depends on tumor context, upstream modifiers, and expression level—features that may critically influence responsiveness to targeted inhibition (Wu et al., 2020; Xu et al., 2022) (Figure 1).